The Valley Desk

ArticleFrontiers in oncologyPublished

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

11 of 32 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Frontiers in oncology
Published
Subject terms
Non-small cell lung cancer (NSCLC); Prognostic Biomarker; Circulating Tumor Dna (Ctdna); Definitive Radiation; Tumor-informed; Molecular Residual Disease (Mrd)
PubMed ID
37795442
PubMed Central ID
PMC10546425
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal